Martin Dow Marker Limited has proudly announced its support for the development of Pakistan’s first-ever “Consensus Guidelines on Constipation in Adults,” officially unveiled at the 41st International Conference of the Pakistan Society of Gastroenterology and GI Endoscopy. The event brought together leading national and international gastroenterologists to celebrate this groundbreaking milestone, which marks the culmination of a two-year collaborative effort.
Read More: CCI Pakistan Boosts Water Replenishment Efforts Through New Funding for Restoring River Ravi Project
Martin Dow Marker played a key role in the project by providing an unconditional educational grant to support the development and publication of the guidelines. The financial contribution enabled the initiative without influencing the clinical content, recommendations, or editorial decisions, all of which were led independently by a panel of medical experts. All contributing authors declared no conflicts of interest, ensuring full academic and ethical transparency throughout the process.
The new guidelines address a major gap in standardized care by offering Pakistan’s first evidence-based framework for the diagnosis, treatment, and management of adult constipation—a condition that is both common and often underdiagnosed. Developed with a focus on local healthcare realities, the guidelines adapt best international practices to Pakistan’s unique demographic, cultural, and clinical context.
Published in the “Pakistan Journal of Medical Sciences,” an internationally recognized peer-reviewed journal, the framework outlines clear clinical pathways for diagnosis and treatment, and emphasizes continuity of care across both urban and rural healthcare settings. The guidelines are also expected to lay the foundation for future research, policy development, and improvements in healthcare infrastructure.
Dr. Atif-Ur-Rehman Khan, Director Business Unit at Martin Dow Marker, stated, “These guidelines reflect our collective commitment to enhancing patient care in Pakistan. We deeply appreciate the invaluable contributions of the medical experts involved. At Martin Dow, we continue to prioritize initiatives that support the advancement of clinical practice across the nation.”
This initiative signals a major advancement in Pakistan’s clinical landscape, helping to ensure that millions of patients receive more consistent and effective care for a frequently overlooked condition. Martin Dow Group remains dedicated to strengthening healthcare outcomes through strategic partnerships and medical innovation.
